Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
Journal of the American Chemical Society|October 18, 2017
Using Hyperfine Electron Paramagnetic Resonance Spectroscopy to Define the Proton-Coupled Electron Transfer Reaction at Fe-S Cluster N2 in Respiratory Complex INolwenn Le Breton, John J Wright, Andrew J Y Jones, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 18, 2010
Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II ConsortiumStephen A Welch, Hal W Hirte, Laurie Elit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2017
Exposure-Response Analysis of Alvocidib (Flavopiridol) Treatment by Bolus or Hybrid Administration in Newly Diagnosed or Relapsed/Refractory Acute Leukemia PatientsCarl LaCerte, Vijay Ivaturi, Joga Gobburu, et al.
Nature Communications|May 19, 2022
Cryo-EM structures define ubiquinone-10 binding to mitochondrial complex I and conformational transitions accompanying Q-site occupancyInjae Chung, John J Wright, Hannah R Bridges, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 26, 2024
The Effect of Reactive Oxygen Species on Respiratory Complex I Activity in LiposomesJana Eisermann, Yuxin Liang, John J Wright, et al.
Cancer|March 2, 2005
A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomasRobert G Maki, Andrew S Kraft, Kelly Scheu, et al.
Investigational New Drugs|March 15, 2011
A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortiumHelen J Mackay, Heather J Au, Elaine McWhirter, et al.
The Journal of Biological Chemistry|February 28, 2021
A conserved arginine residue is critical for stabilizing the N2 FeS cluster in mitochondrial complex IMikhail A Hameedi, Daniel N Grba, Katherine H Richardson, et al.
Clinical Lymphoma & Myeloma|April 14, 2009
Bortezomib in relapsed or refractory Waldenström's macroglobulinemiaChristine Chen, C Tom Kouroukis, Darrell White, et al.
Investigational New Drugs|July 12, 2008
A phase I study of bortezomib, etoposide and carboplatin in patients with advanced solid tumors refractory to standard therapyChristopher Lieu, Laura Chow, A Scott Pierson, et al.
Pageof 15